CA2314683A1 - Emploi therapeutique de vecteurs lentiviraux - Google Patents
Emploi therapeutique de vecteurs lentiviraux Download PDFInfo
- Publication number
- CA2314683A1 CA2314683A1 CA002314683A CA2314683A CA2314683A1 CA 2314683 A1 CA2314683 A1 CA 2314683A1 CA 002314683 A CA002314683 A CA 002314683A CA 2314683 A CA2314683 A CA 2314683A CA 2314683 A1 CA2314683 A1 CA 2314683A1
- Authority
- CA
- Canada
- Prior art keywords
- vector
- cells
- hiv
- gene
- transgene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
L'invention porte sur un vecteur lentiviral inhibant la propagation d'un lentivirus dans une cellule.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6957997P | 1997-12-12 | 1997-12-12 | |
US60/069,579 | 1997-12-12 | ||
PCT/US1998/025720 WO1999030742A1 (fr) | 1997-12-12 | 1998-12-11 | Emploi therapeutique de vecteurs lentiviraux |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2314683A1 true CA2314683A1 (fr) | 1999-06-24 |
Family
ID=22089926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002314683A Abandoned CA2314683A1 (fr) | 1997-12-12 | 1998-12-11 | Emploi therapeutique de vecteurs lentiviraux |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1037669A4 (fr) |
JP (1) | JP2002508338A (fr) |
KR (1) | KR20010033062A (fr) |
AU (1) | AU749059B2 (fr) |
CA (1) | CA2314683A1 (fr) |
WO (1) | WO1999030742A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1013601A (en) | 1999-10-22 | 2001-05-08 | Aventis Pasteur Limited | Method of inducing and/or enhancing an immune response to tumor antigens |
US6656706B2 (en) | 1999-12-23 | 2003-12-02 | The United States Of America As Represented By The Department Of Health And Human Services | Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes |
CA2408328C (fr) | 2000-05-10 | 2012-04-17 | Aventis Pasteur Limited | Polypeptides immunogeniques codes par des minigenes mage et leurs utilisations |
US6712612B1 (en) | 2000-12-12 | 2004-03-30 | Genecure Llc | Safe and stable retroviral helper cell line and related compositions and methods |
EP1594459B1 (fr) | 2002-12-30 | 2010-02-17 | Angiotech International Ag | Liberation de medicaments a partir d'une composition polymere a gelification rapide |
CA2523138C (fr) | 2003-04-24 | 2013-04-23 | Fondazione Centro San Raffaele Del Monte Tabor | Vecteurs lentiviraux portant des promoteurs bidirectionnels de synthese, et leurs utilisations |
WO2009049351A1 (fr) | 2007-10-15 | 2009-04-23 | The University Of Queensland | Système de construction et utilisations pour celui-ci |
US9795658B2 (en) | 2010-04-20 | 2017-10-24 | Admedus Vaccines Pty Ltd | Expression system for modulating an immune response |
AU2016367712B2 (en) | 2015-12-09 | 2021-10-07 | Jingang Medicine (Australia) Pty Ltd | Immunomodulating composition for treatment |
WO2018018082A1 (fr) | 2016-07-26 | 2018-02-01 | The Australian National University | Compositions immunostimulantes et utilisations de celles-ci |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3325579B2 (ja) * | 1995-03-16 | 2002-09-17 | 久光製薬株式会社 | 新規遺伝子組換え体 |
US5650309A (en) * | 1995-05-16 | 1997-07-22 | The Regents Of The University Of California | Viral vectors |
US6013516A (en) * | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
AU1123497A (en) * | 1995-11-28 | 1997-06-19 | Clinical Technologies, Inc. | Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome |
CN1651577A (zh) * | 1995-11-28 | 2005-08-10 | 约翰斯·霍普金斯大学医学院 | 条件复制型病毒载体及其用法 |
AP964A (en) * | 1996-02-21 | 2001-05-11 | Julianna Lisziewicz | Methods and compositions for protective and therapeutic genetic immunisation. |
CA2247091A1 (fr) * | 1996-03-05 | 1997-09-12 | The Regents Of The University Of California | Virus de l'immunodeficience feline vivants recombines et vaccins d'adn proviraux |
DE69737597D1 (de) * | 1996-07-22 | 2007-05-24 | Us Gov Health & Human Serv | Vektoren zur inhibierung von viralem und tumorwachstum |
US20020123471A1 (en) * | 1997-03-06 | 2002-09-05 | Klaus Uberla | Lentivirus based vector and vector system |
GB9704977D0 (en) * | 1997-03-11 | 1997-04-30 | Univ Glasgow | FIV vaccine |
EP1003894A2 (fr) * | 1997-07-18 | 2000-05-31 | Chiron Corporation | Vecteurs lentiviraux |
-
1998
- 1998-12-11 AU AU18035/99A patent/AU749059B2/en not_active Ceased
- 1998-12-11 WO PCT/US1998/025720 patent/WO1999030742A1/fr not_active Application Discontinuation
- 1998-12-11 JP JP2000538720A patent/JP2002508338A/ja active Pending
- 1998-12-11 EP EP98962895A patent/EP1037669A4/fr not_active Withdrawn
- 1998-12-11 KR KR1020007006423A patent/KR20010033062A/ko not_active Application Discontinuation
- 1998-12-11 CA CA002314683A patent/CA2314683A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1037669A1 (fr) | 2000-09-27 |
JP2002508338A (ja) | 2002-03-19 |
AU1803599A (en) | 1999-07-05 |
WO1999030742A1 (fr) | 1999-06-24 |
EP1037669A4 (fr) | 2003-04-02 |
KR20010033062A (ko) | 2001-04-25 |
AU749059B2 (en) | 2002-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4190579B2 (ja) | 非***細胞への核酸運搬のためのベクターおよび使用方法 | |
US9260725B2 (en) | Methods and compositions relating to improved lentiviral vector production systems | |
JP4390860B2 (ja) | レンチウイルスをベースにした遺伝子転移ベクター | |
US5635399A (en) | Retroviral vectors expressing cytokines | |
US20180251786A1 (en) | Recombinant vectors comprising 2a peptide | |
CA2328404C (fr) | Nouvelles cellules lentivirales d'encapsidation | |
KR20010033064A (ko) | 높은 역가를 갖는 안전한 재조합 렌티바이러스 벡터를생성시키는 방법 및 수단 | |
WO1997012622A9 (fr) | Vecteur et procede permettant d'alimenter en acide nucleique des cellules ne subissant pas de division | |
JPH10507905A (ja) | ヒト血清による溶解耐性生産者細胞系で生産されるレトロウイルスベクター | |
JP2002518997A (ja) | レトロウイルス送達システム | |
US20140170709A1 (en) | Vector for gene therapy | |
AU749059B2 (en) | Therapeutic use of lentiviral vectors | |
EP0970201A1 (fr) | Vecteurs retroviraux pouvant transduire des cellules ne se divisant pas | |
US6130089A (en) | Materials and methods for gene transfer | |
DE69829174T2 (de) | Exprimierung eines modifiziertem "foamy virus envelope protein" (hüllenprotein) | |
CA2233867C (fr) | Vecteur et procede permettant d'alimenter en acide nucleique des cellules ne subissant pas de division | |
AU758600B2 (en) | Vector and method of use for nucleic acid delivery to non-dividing cells | |
Joseph | Non-integrating integrase and long terminal repeat attachment site mutant HIV-1-derived lentiviral vectors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |